The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of … DE Connor, T Exner, DDF Ma, JE Joseph Thrombosis and haemostasis 103 (05), 1044-1052, 2010 | 400 | 2010 |
Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens S Shumack, J Robinson, S Kossard, L Golitz, H Greenway, A Schroeter, ... Archives of dermatology 138 (9), 1165-1171, 2002 | 272 | 2002 |
Consensus Document of the International Union of Angiology (IUA)-2013 Current concepts on the management of arterio-venous malformations BB Lee, I Baumgartner, HP Berlien, G Bianchini, P Burrows, YS Do, ... Int Angiol 32 (1), 9-36, 2013 | 245 | 2013 |
Diagnosis and treatment of venous malformations. Consensus document of the international union of phlebology (IUP): updated 2013. BB Lee, I Baumgartner, P Berlien, G Bianchini, P Burrows, P Gloviczki, ... International angiology: a journal of the International Union of Angiology …, 2015 | 208 | 2015 |
Complications of foam sclerotherapy A Cavezzi, K Parsi Phlebology 27 (1_suppl), 46-51, 2012 | 194 | 2012 |
Venous hemodynamic changes in lower limb venous disease: the UIP consensus according to scientific evidence BB Lee, AN Nicolaides, K Myers, M Meissner, E Kalodiki, C Allegra, ... Int Angiol 35 (3), 236-352, 2016 | 174 | 2016 |
Diagnosis and treatment of venous malformations. Consensus document of the International Union of Phlebology (IUP)-2009 BB Lee, J Bergan, P Gloviczki, J Laredo, DA Loose, R Mattassi, K Parsi, ... Int Angiol 28 (6), 434-451, 2009 | 155 | 2009 |
Diagnosis and treatment of primary lymphedema. Consensus document of the International Union of Phlebology (IUP)-2009 B Lee, M Andrade, J Bergan, F Boccardo, C Campisi, R Damstra, M Flour, ... Int Angiol 29 (5), 454-470, 2010 | 134 | 2010 |
The lytic effects of detergent sclerosants on erythrocytes, platelets, endothelial cells and microparticles are attenuated by albumin and other plasma components in vitro K Parsi, T Exner, DE Connor, A Herbert, DDF Ma, JE Joseph European Journal of Vascular and Endovascular Surgery 36 (2), 216-223, 2008 | 126 | 2008 |
Hemangiomas and vascular malformations: an atlas of diagnosis and treatment R Mattassi, DA Loose, M Vaghi springer, 2015 | 104 | 2015 |
Catheter-directed sclerotherapy K Parsi Phlebology 24 (3), 98-107, 2009 | 102 | 2009 |
Paradoxical embolism, stroke and sclerotherapy K Parsi Phlebology 27 (4), 147-167, 2012 | 99 | 2012 |
Interaction of detergent sclerosants with cell membranes K Parsi Phlebology 30 (5), 306-315, 2015 | 92 | 2015 |
Chronic urticaria due to Blastocystis hominis R Gupta, K Parsi Australasian journal of dermatology 47 (2), 117-119, 2006 | 85 | 2006 |
In vitro effects of detergent sclerosants on coagulation, platelets and microparticles K Parsi, T Exner, DE Connor, DDF Ma, JE Joseph European Journal of Vascular and Endovascular Surgery 34 (6), 731-740, 2007 | 82 | 2007 |
ISVI-IUA consensus document diagnostic guidelines of vascular anomalies: vascular malformations and hemangiomas BB Lee, PL Antignani, V Baraldini, I Baumgartner, P Berlien, F Blei, ... International angiology: a journal of the International Union of Angiology …, 2015 | 74 | 2015 |
Society for Vascular Surgery and American Venous Forum Guidelines on the management of venous leg ulcers: the point of view of the International Union of Phlebology G Mosti, M De Maeseneer, A Cavezzi, K Parsi, N Morrison, O Nelzén, ... International angiology: a journal of the International Union of Angiology …, 2015 | 73 | 2015 |
Global guidelines trends and controversies in lower limb venous and lymphatic disease: Narrative literature revision and experts’ opinions following the vWINter international … S Gianesini, A Obi, S Onida, D Baccellieri, D Bissacco, D Borsuk, ... Phlebology 34 (1_suppl), 4-66, 2019 | 72 | 2019 |
Three cases of stroke following peripheral venous interventions RWL Ma, A Pilotelle, P Paraskevas, K Parsi Phlebology 26 (7), 280-284, 2011 | 59 | 2011 |
Detergent sclerosants are deactivated and consumed by circulating blood cells DE Connor, O Cooley-Andrade, WX Goh, DDF Ma, K Parsi European Journal of Vascular and Endovascular Surgery 49 (4), 426-431, 2015 | 56 | 2015 |